Philipp Berning

Philipp Berning studied medicine at the University of Muenster, Germany, University of Nantes, France and University of Bern, Switzerland. While in medical school, he studied the role of CXCR4 signaling in Ewing’s sarcoma under the supervision of Professor Uta Dirksen and received his Dr. med. from the University of Muenster. Subsequently, he joined the Department of Hematology and Oncology at the University of Muenster and started his postdoctoral training under the supervision of Professor Georg Lenz working on PI3K/AKT/mTOR signaling in aggressive B-cell lymphomas. Before joining the Müschen Lab, he completed his residency and clinical fellowship training at the University of Muenster with Professor Georg Lenz in 2023.